As of March 2026 Immunovant has a market cap of A$7.19 Billion. This makes Immunovant the world's 3004th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 16th, 2026 the market cap of Immunovant was reported to be: